Prevention of Chemotherapy-induced Myelosuppression in SCLC patients treated with the Dual MDMX/MDM2 Inhibitor ALRN-6924. (October 2020) - Andric, Z.; Ceric, T.; Stanetic, M.; Rancic, M.; Jakopovic, M.; Aix, S. Ponce; Ramlau, R.; Smit, E.; Ulanska, M.; Caldwell, C.; Ferrari, D.; Annis, A.; et al.